Skip to main content
. Author manuscript; available in PMC: 2023 Aug 29.
Published in final edited form as: Vaccine. 2017 May 19;35(36):4769–4776. doi: 10.1016/j.vaccine.2017.04.036

Table 3.

Performance of the acute flaccid paralysis (AFP) surveillance – Ukraine, 2003–2016.

Variables 2008 2009 2010 2011 2012 2013 2014 2015 2016a Target
Reported AFP cases, No. 105 104 130 127 120 118 133 154 125 N/A
Confirmed polio cases, No. 0 0 0 0 0 0 0 3 (cVDPV1–2, VAPP–1) 0 0
Polio-compatible cases, No. 0 0 0 0 0 0 0 0 0 0
Non-polio AFP rate 1.67 1.70 2.10 2.05 2.01 2.09 2.18 2.67 1.97 ≥1.0b
AFP surveillance indexc 0.92 0.81 0.94 0.94 0.83 0.92 0.86 0.84 0.68 ≥0.8
AFP cases with 2 adequate stool specimens, %d 95.6 86.6 94.4 93.9 87.5 94.4 89.1 86.3 82.7 ≥80%
a

2016 data are preliminary, as reported by week 35 2016; non-polio AFP rates and surveillance index for 2016 are annualized.

b

The target for non-polio AFP rate 2.0/100,000 applies to countries at high risk of poliovirus spread and 3.0/100,000 to countries with active polio outbreak.

c

Non-polio AFP rate up to 1.0 multiplied by the proportion of cases with stool specimen.

d

Per cent of AFP cases with 2 stool specimens collected 24–48 h apart within 14 days of onset.